SIX:BION

BB Biotech AG · SIX · Financial Services · CHF · FY for 2025

Figures on this page computed 2026-11-08 12:56 UTC

Last close

n/aCHF

Market data

  • 4.9xP/E

    Price / Earnings per Share (diluted)

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CHF
    • computed
    • Computed from the filing for 2025
  • n/aROIC

    We do not hold this figure for this company, so there is nothing to place.

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CHF
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • n/mNet marginnet income exceeds revenue

    Net income exceeds revenue.

    Net Income / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CHF
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 402.5%FCF margin

    Free Cash Flow / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CHF
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • n/aDebt/equity

    We do not hold this figure for this company, so there is nothing to place.

    Total Debt / Shareholders' Equity

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CHF
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 3.5%Dividend yield
    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CHF
    • computed

Five bars, one line

lens 7 of 9
0.14x
1.11x
0.66x
n/a
n/a
SalesProfitFree cash flowDebtPrice
Each bar against this company's own average; the line is that average.
Computed2025
Computed2025
Computed2025
Computed2025
Market datan/a

Each against its own average

3 of 5 read

Except where said otherwise: Computed from the filing for 2025

  • Sales0.14x

    Its own average over 10 years, 534.0M.

  • Profit1.11x

    Its own average over 10 years, 520.1M.

  • Free cash flow0.66x

    Its own average over 10 years, 469.4M.

  • Debtn/a

    Its own average over 9 years, 152.6M.

  • Pricen/a

    Its own average over 0 years. Market data

Sales is furthest from its own average, at 0.14 times.

Sales is 0.14 times its own 10-year average; Profit is 1.11 times its own 10-year average; Free cash flow is 0.66 times its own 10-year average.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

  • Sales against its own 10-year average0.14
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    CHF
  • Profit against its own 10-year average1.11
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    CHF
  • Free cash flow against its own 10-year average0.66
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    CHF
  • Debt against its own 9-year averagen/a

    Not held.

    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    CHF
  • Price against its own 0-year averagen/aMarket data

    Not held.

    Source
    market
    Reported in
    CHF

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.